Product Description
Metatime 500 Tablet is an oral anti-diabetic medicine that helps manage Type 2 Diabetes Mellitus and supports the treatment of Polycystic Ovary Syndrome (PCOS) in women. By effectively controlling blood sugar levels, it reduces the risk of diabetes-related complications such as kidney damage, nerve pain, and vision problems. In women with PCOS, it improves hormonal balance, restores ovulation, and regulates menstrual cycles.
This medicine works best when combined with a healthy diet and regular exercise. Take Metatime 500 Tablet with food to minimize stomach upset and nausea. Always take it at the same time every day as directed by your doctor. Do not stop using it suddenly without consulting your healthcare provider.
Key Benefits
Controls blood sugar levels: Helps prevent complications such as neuropathy, nephropathy, and retinopathy.
Manages PCOS symptoms: Restores ovulation, regulates periods, and improves fertility outcomes.
Enhances insulin sensitivity: Helps your body use insulin more effectively to lower glucose levels.
Supports weight management: Aids in reducing excess weight, especially in women with PCOS.
Promotes metabolic health: Reduces the risk of cardiovascular and hormonal imbalances.
How Metatime 500 Tablet Works
Metatime 500 Tablet contains Metformin, a biguanide-class anti-diabetic agent. It works by:
Decreasing glucose production in the liver
Delaying sugar absorption from the intestines
Enhancing the body’s sensitivity to insulin
In women with PCOS, Metatime 500 Tablet helps reduce insulin resistance, which in turn lowers androgen levels, leading to improved ovulation, reduced acne, less unwanted hair growth, and better hormonal balance.
Directions for Use
Take the tablet exactly as prescribed by your doctor.
Swallow the tablet whole with water—do not crush, chew, or break it.
Always take it with food to reduce nausea and stomach discomfort.
Maintain a consistent schedule for better glucose control.
Follow your doctor’s advice on diet, exercise, and lifestyle for optimal results.
Possible Side Effects
Most side effects are mild and subside as your body adapts to the medicine. If symptoms persist, contact your doctor.
Common side effects include:
Diarrhea or nausea
Vomiting or abdominal discomfort
Loss of appetite
Headache or weakness
Rarely, when combined with other anti-diabetic medicines or alcohol, it may cause hypoglycemia (low blood sugar) — watch for symptoms such as dizziness, sweating, or palpitations.
Safety Information
Alcohol: Unsafe – avoid alcohol as it can increase the risk of lactic acidosis.
Pregnancy: Safe if prescribed – generally considered safe under medical supervision.
Breastfeeding: Use with caution – consult your doctor before use during breastfeeding.
Driving: Caution – avoid driving if you feel dizzy or experience symptoms of low blood sugar.
Kidney: Use with caution – may require dose adjustment in patients with kidney issues; avoid in severe renal impairment.
Liver: Safe if prescribed – usually does not require dose adjustment in mild to moderate liver disease.
Precautions
Monitor your blood sugar regularly as advised.
Do not skip meals while on this medication.
Avoid excessive alcohol consumption.
Inform your doctor about any existing kidney, heart, or liver problems.
Keep out of reach of children and store in a cool, dry place away from direct sunlight.
Uses of Metatime 500 Tablet
Management of Type 2 Diabetes Mellitus
Treatment of Polycystic Ovary Syndrome (PCOS)
Improvement of insulin sensitivity and glucose metabolism
Product Summary
Attribute Details
Composition Metformin Hydrochloride 500 mg
Therapeutic Class Anti-diabetic / Insulin Sensitizer
Form Tablet
Route of Administration Oral
Dosage As prescribed by the physician
Storage Store below 30°C in a cool, dry place away from sunlight
Product Variants & Keywords
Keywords: Metatime 500 Tablet, Metatime Tablet, Metatime 500, Metatime for PCOS, Metatime 500 diabetes medicine, Metatime 500 uses, Metatime 500 side effects, Metatime 500 dosage, Metformin 500 mg tablet





Reviews
There are no reviews yet.